YR, P., B. . M, and S. . CK. “GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF 25 MG FULL TABLET VERSUS 12.5 MG HALF TABLET EMPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES (T2D): A SINGLE CENTRE EXPERIENCE”. Journal of the ASEAN Federation of Endocrine Societies, vol. 36, July 2021, p. 44, doi:10.15605/jafes.036.S60.